C

    Cerus Corporation (CERS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.64
    -0.01 (-0.38%)

    Market Cap: $534.04M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    70%(28/40)
    Avg Surprise
    +6.09%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.02 - $-0.01
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.01+33.3%
    60d ago$-0.01+33.3%
    30d ago$-0.01+33.3%
    7d ago$-0.01+33.3%
    Current$-0.01
    Revenue Consensus
    $61M
    Range$58M - $63M
    2 analysts
    Dec 31, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.02
    2 analysts
    Revenue Consensus
    $78M
    Range$62M - $86M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.01---
    Jun 26
    		$-0.01$-0.01+0.00%Beat+66.7%
    Mar 26
    		$-0.01N/A+75.00%Beat+75.0%
    Dec 25
    		$-0.01$-0.01-33.33%Miss+0.0%
    Sep 25
    		$-0.00N/A+99.50%Beat+99.5%
    Jun 25
    		$-0.03$-0.02-50.00%Miss+0.0%
    Mar 25
    		$-0.04$-0.05+20.00%Beat+20.0%
    Dec 24
    		$-0.01$-0.01+0.00%Beat+0.0%
    Sep 24
    		$-0.02$-0.03+33.33%Beat+33.3%
    Jun 24
    		$-0.03$-0.04+25.00%Beat+50.0%
    Mar 24
    		$-0.05$-0.04-25.00%Miss+44.4%
    Dec 23
    		$-0.01$-0.02+50.00%Beat+87.5%
    Sep 23
    		$-0.03$-0.05+40.00%Beat+40.0%
    Jun 23
    		$-0.06$-0.06+0.00%Beat+0.0%
    Mar 23
    		$-0.09$-0.07-28.57%Miss-28.6%
    Dec 22
    		$-0.08$-0.05-60.00%Miss-60.0%
    Sep 22
    		$-0.05$-0.05+0.00%Beat+28.6%
    Jun 22
    		$-0.06$-0.06+0.00%Beat+33.3%
    Mar 22
    		$-0.07$-0.08+12.50%Beat+30.0%
    Dec 21
    		$-0.05$-0.08+37.50%Beat+44.4%
    Sep 21
    		$-0.07$-0.10+30.00%Beat+12.5%
    Jun 21
    		$-0.09$-0.09+0.00%Beat+0.0%
    Mar 21
    		$-0.10$-0.09-11.11%Miss+0.0%
    Dec 20
    		$-0.09$-0.09+0.00%Beat+25.0%
    Sep 20
    		$-0.08$-0.10+20.00%Beat+38.5%
    Jun 20
    		$-0.09$-0.10+10.00%Beat+30.8%
    Mar 20
    		$-0.10$-0.10+0.00%Beat+28.6%
    Dec 19
    		$-0.12$-0.12+0.00%Beat+0.0%
    Sep 19
    		$-0.13$-0.12-8.33%Miss-18.2%
    Jun 19
    		$-0.13$-0.12-8.33%Miss-30.0%
    Mar 19
    		$-0.14$-0.11-27.27%Miss-27.3%
    Dec 18
    		$-0.12$-0.11-9.09%Miss-20.0%
    Sep 18
    		$-0.11$-0.10-10.00%Miss+8.3%
    Jun 18
    		$-0.10$-0.11+9.09%Beat+37.5%
    Mar 18
    		$-0.11$-0.11+0.00%Beat+38.9%
    Dec 17
    		$-0.10$-0.11+9.09%Beat+23.1%
    Sep 17
    		$-0.12$-0.16+25.00%Beat+14.3%
    Jun 17
    		$-0.16$-0.16+0.00%Beat-
    Mar 17
    		$-0.18$-0.16-12.50%Miss-
    Dec 16
    		$-0.13$-0.15+13.33%Beat-
    Sep 16
    		$-0.14$-0.17+17.65%Beat-

    Key Metrics

    Valuation
    P/E Ratio-87.71EV/EBITDA195.90x
    Price/FCF-289.50xFCF Yield-0.35%
    Profitability
    Profit Margin-3.06%Operating Margin-3.24%
    ROE-10.80%ROIC0.91%
    Financial Health
    Debt/Equity0.93xInterest Coverage0.16x
    Current Ratio1.83xQuick Ratio1.07x
    Trading Statistics
    Beta1.77Avg Volume2.57M
    52-Week High$3.4752-Week Low$1.17

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.74
    SMA 20$2.65
    SMA 50$2.83
    SMA 200$2.35
    EMA 10$2.71
    EMA 20$2.72
    EMA 50$2.73
    EMA 200$2.37

    MACD

    Line: -0.02Signal: -0.02Hist: -0.00

    ADX

    ADX: 13.4+DI: 21.0-DI: 28.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down16.0
    PSAR$3.07

    Bollinger Bands

    Upper Band$3.10
    Lower Band$2.21
    %B Position3364%(Upper)
    Band Width0.48

    RSI (14-Day)

    Neutral
    45.5

    Momentum Oscillators

    Stoch %K31.7
    Stoch %D44.8
    Williams %R-84.5
    ROC (10d)-11.1%
    Momentum-0.33
    CCI (20d)-10.0
    MFI (14d)58.3

    Volatility Measures

    ATR (14d)$0.15(5.7%)
    StdDev (20d)0.22
    Hist Vol54.9%(High)

    Volume Flow

    VWAP$2.62
    OBV63.4M
    AD Line-6.0M
    CMF (20d)0.089

    Volume Metrics

    Avg Vol (20d)2.5M
    Vol Ratio0.5x
    VWMA (20d)$2.60

    Pivot Points

    R3$2.81
    R2$2.77
    R1$2.71
    Pivot Point$2.67
    S1$2.61
    S2$2.57
    S3$2.51

    Advanced Oscillators

    TSI-2.75
    Ultimate Osc38.5
    KST-15.03

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$57.44M$53.66M$64.58M$60.24M$52.45M$43.24M$56.75M$50.66M$50.52M$43.40M$53.34M$47.25M
    Cost of Revenue$27.91M$25.77M$28.00M$24.56M$23.47M$17.82M$23.42M$19.82M$20.41M$17.09M$20.81M$17.96M
    Gross Profit$29.53M$27.89M$29.75M$28.14M$28.98M$25.42M$27.39M$26.20M$24.67M$21.27M$25.96M$21.82M
    Operating Expenses$31.39M$28.25M$37.22M$34.44M$32.40M$31.28M$34.78M$31.80M$33.94M$34.28M$31.56M$34.54M
    R&D$14.39M$14.53M$16.39M$15.82M$18.90M$16.61M$15.44M$14.01M$14.97M$14.48M$14.29M$16.78M
    SG&A$22.86M$19.95M$20.83M$18.62M$21.18M$20.29M$19.33M$17.79M$18.97M$19.80M$17.27M$16.16M
    Operating Income$-1,858,000$-354,000$-641,000$1.24M$-3,423,000$-5,853,000$-1,449,000$-961,000$-3,836,000$-7,979,000$976,000$-5,243,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.71M$1.87M$1.96M$2.12M$2.15M$2.11M$2.05M$2.26M$2.33M$2.23M$2.23M$2.36M
    Income Before Tax$-2,887,000$-1,557,000$-2,065,000$65,000$-5,639,000$-7,644,000$-2,451,000$-2,858,000$-5,831,000$-9,616,000$-1,317,000$-7,208,000
    Income Tax Expense$95,000$91,000$119,000$85,000$76,000$74,000$111,000$76,000$-56,000$74,000$72,000$78,000
    Net Income$-2,982,000$-1,648,000$-2,184,000$-20,000$-5,715,000$-7,718,000$-2,562,000$-2,934,000$-5,775,000$-9,690,000$-1,389,000$-7,286,000
    EBITDA$-712,000$762,000$292,000$2.57M$-3,145,000$-5,227,000$-66,000$-186,000$-3,021,000$-6,751,000$1.56M$-4,167,000
    EBIT$-1,173,000$315,000$-101,000$2.18M$-3,489,000$-5,534,000$-398,000$-598,000$-3,501,000$-7,382,000$912,000$-4,844,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CERS

    Government Contracts

    Gov Obligations (TTM)
    $33.70M
    Gov Obligations / Revenue
    15.2%
    Obligations YoY
    3.3%
    Active Awards
    13
    New Awards (TTM)
    3
    Avg Remaining Term
    21.9 mo

    Top agency: Department of Health and Human Services at 98.8% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026P00071Department of Health and Human ServicesNational Institutes of Health$225336Mar 9, 2026
    75N90025P00719Department of Health and Human ServicesNational Institutes of Health$115899Sep 12, 2025
    W81K0225PA067Department of DefenseDefense Health Agency$71596Oct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Cerus Corp chief legal officer sells $89,529 in company stock.

    Cerus Corp's Chief Legal Officer, Chrystal Jensen, sold 30,000 shares of company stock for $89,529 on August 17, 2026, as part of a pre-arranged trading plan. This sale occurred while Cerus shares were trading near $2.97, having increased significantly over the past year. Despite the insider sale, the company recently surpassed Q2 2026 financial expectations, though concerns about margin pressure and short-term cash usage persist.

    Investing.com•8/18/26•
    Somewhat-Bearish

    Cerus (NASDAQ: CERS) insider moves to sell more stock after July sale

    Chrystal Nikole Jensen, an insider at Cerus (NASDAQ: CERS), has filed a Form 144 notice to sell up to 30,000 shares of common stock through Morgan Stanley Smith Barney LLC on August 17, 2026. This proposed sale follows a previous sale of 24,329 common shares on July 1, 2026, within the last three months. The filing also details prior restricted stock awards to Jensen in 2021 and 2022.

    Stock Titan•8/18/26•
    Neutral

    Cerus Corp chief legal officer sells $89,529 in company stock.

    Chrystal Jensen, Chief Legal Officer at Cerus Corp (NASDAQ:CERS), sold 30,000 shares of company stock totaling $89,529 on August 17, 2026, as part of a pre-arranged trading plan. The sale occurred while Cerus shares were trading near $2.97, reflecting significant gains over the past year. Despite positive Q2 2026 financial results, including an earnings beat and raised revenue guidance, the company faced concerns regarding margin pressure and cash usage.

    Investing.com•8/18/26•
    Somewhat-Bearish

    Cerus Corp chief legal officer sells $89,529 in company stock. By Investing.com

    Cerus Corp's Chief Legal Officer, Chrystal Jensen, sold 30,000 shares of company stock totaling $89,529 on August 17, 2026, as part of a pre-arranged trading plan. This sale occurred while Cerus shares were trading near $2.97, reflecting significant gains over the past year and week, though InvestingPro analysis suggests the stock might be slightly overvalued. The company recently reported strong Q2 2026 financial results, exceeding revenue and profit forecasts, despite concerns about margin pressure and short-term cash usage.

    Investing.com India•8/18/26•
    Somewhat-Bearish

    Cerus (CERS) legal chief sells 30,000 shares in preset plan

    Cerus (CERS) Chief Legal Officer Chrystal Jensen sold 30,000 shares of common stock on August 17, 2026, as part of a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $2.9843, with individual prices ranging from $2.92 to $3.04. Following this transaction, Jensen directly holds 936,657 shares of Cerus common stock.

    Stock Titan•8/18/26•
    Somewhat-Bearish

    Frequently Asked Questions About CERS

    Does CERS pay dividends?
    Cerus Corporation (CERS) does not currently pay a regular dividend.
    What is CERS's market cap?
    Cerus Corporation (CERS) has a market capitalization of $534.04M with a current stock price of $2.64.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In